rpoB mutations in Streptococcus mitis clinical isolates resistant to rifampin

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 7, 2004, Pages 2757-2759

  Achour, Wafa ^a   Guenni, Olfa ^a   Fines, Marguerite ^b   Leclercq, Roland ^b,c   Hassen, Assia Ben ^a  

^a CENTRE NATIONAL DE GREFFE DE MOELLE OSSEUSE   (Tunisia)

^b CHU CÔTE DE NACRE   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIAL PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DNA; ERYTHROMYCIN; FOSFOMYCIN; LINCOMYCIN; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; TETRACYCLINE;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIUM MUTANT; CANCER PATIENT; CONTROLLED STUDY; GENE MUTATION; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RPOB GENE; STRAIN DIFFERENCE; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS MITIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANTIBIOTICS, ANTITUBERCULAR; DNA PRIMERS; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; NEUTROPENIA; RIFAMPIN; SEQUENCE ANALYSIS, PROTEIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS MITIS;

EID: 3042623965     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.7.2757-2759.2004     Document Type: Article

References (17)

1. Asoh, N., H. Watanabe, M. Fines-Guyon, K. Watanabe, K. Oishi, W. Kositsakulshai, T. Sanchai, K. Kunsuikmengrai, S. Kahintapong, B. Khantawa, P. Tharavichitkul, T. Siriranthana, and T. Nagatake. 2003. Emergence of rifampin-resistant Rhodococcus equi with several types of mutations in the rpoB gene among AIDS patients in northern Thailand. J. Clin. Microbiol. 41:2337-2340.
2. Aubry-Damon, H., M. Galimand, G. Gerbaud, and P. Courvalin. 2002. rpoB mutation conferring rifampin resistance in Streptococcus pyogenes. Antimicrob. Agents Chemother. 46:1571-1573.
3. Aubry-Damon, H., C.-J. Soussy, and P. Courvalin. 1998. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 42:2590-2594.
4. Bryskier, A. 2002. Viridans group streptococci: a reservoir of resistant bacteria in oral cavities. Clin. Microbiol. Infect. 2:65-69.
5. Enright, M., P. Zawadski, P. Pickerill, and C. Dawson. 2000. Molecular evolution of rifampin resistance in Streptococcuspneumoniae. Microb. Drug Resist. 4:65-70.
6. Fines, M., S. Pronost, K. Maillard, S. Taouji, and R. Leclercq. 2001. Characterization of mutations in the rpoB gene associated with rifampin resistance in Rhodococcus equi isolated from foals. J. Clin. Microbiol. 39.2784-2787.
7. Herrera, L., C. Salcedo, B. Orden, B. Herranz, R. Martinez, A. Efstratiou, and J. A. Saéz Nieto. 2002. Rifampin resistance in Streptococcus pyogenes. Eur. J. Clin. Microbiol. Infect. Dis. 21:411-413.
8. Jacobs, M. R., H. J. Koornhof, R. M. Robins-Browne, C. M. Stevenson, Z. A. Vermaak, I. Freeman, J. B. Miller, M. A. Witcomb, M. Isaacson, I. J. Ward, and R. Austrian. 1978. Emergence of multiply resistant pneumococci. N. Engl. J. Med. 299:735-740.
9. Meier, P. S., S. Utz, S. Aebi, and K. Mühlemann. 2003. Low-level resistance to rifampin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47:863-868.
10. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. Ohno, H., H. Koga, S. Kohno, T. Tashiro, and IL Hara. 1996. Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob. Agents Chemother. 40:1053-1056.
12. Padayachee, T., and K. P. Klugman. 1999. Molecular basis of rifampin resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43:2361-2365.
13. Severinov, K., A. Mustaev, E. Severinova, M. Koslov, S. A. Darst, and A. Golfarb. 1995. The beta subunit Rif-cluster I is only angstroms away from the active center of Escherichia coli RNA polymerase. J. Biol. Chem. 270:29428-29432.
14. Stefanelli, P., C. Fazio, G. La Rosa, C. Marianelli, M. Muscillo, and P. Mastrantino. 2001. Rifampin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strain. J. Antimicrob. Chemother. 47:219-222.
15. Vogler, A. J., J. D. Busch, S. Percy-Fine, C. Tipton-Hunton, K. L. Smith, and P. Keim. 2002. Molecular analysis of rifampin resistance in Bacillus anthracis and Bacillus cereus. Antimicrob. Agents Chemother. 46:511-513.
16. Wichelhaus, T. A., V. Schäfer, V. Brade, and B. Böddinghaus. 1999. Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 43:2813-2816.
17. Wichelhaus, T. A., V. Schäfer, V. Brade, and B. Böddinghaus. 2001. Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus. J. Antimicrob. Chemother. 47:153-156.